Financial Modeling & Valuation for Life Sciences & Pharmaceutical companies | Portfolio construction & performance | Quantitative Screening & Fundamental Research | Budgeting | FP&A Financial Planning & Analysis | 12 month rolling forecast | Long range financial planning | Leadership | Direct ...more

Financial Modeling & Valuation for Life Sciences & Pharmaceutical companies | Portfolio construction & performance | Quantitative Screening & Fundamental Research | Budgeting | FP&A Financial Planning & Analysis | 12 month rolling forecast | Long range financial planning | Leadership | Direct Reports | Pricing and Revenue Optimization, B2B Pricing Strategy for Medtech & Medical Devices Performs company-specific, macro, and industry research of both existing and potential investments weighing factors such as Value, Earnings Quality, Momentum & Earnings Growth. Expertise in financial, regulatory and valuation drivers of healthcare companies. Execute a multi-faceted role within all-encompassing financial planning and analysis position, contributing to budgeting, forecasting, and ad-hoc analysis for the CV franchise. Work closely with Finance Leadership Team (FLT) to develop a strategy to achieve financial goals on a monthly, quarterly & annual basis. M&A Transactions & LBO Modeling | DCF, Multiples Valuation | Financial Reports & Presentations | Revenue Deductions (Gross-to-Net Calculations) | P&L Management / TRx & NBRx Sales Forecast | Financial Reporting Systems (SAP, IBM-TM1) | US-GAAP vs IFRS for Pharmaceutical Industry | Qualitative & Quantitative Market Research | Forecasting & Market Sizing | Competitive Intelligence | Epidemiology US & Global Experience | Anaplan | Scarsin i2e | Variance Analysis Budget to Actuals, Forecast to Actuals | Financial Planning | Financial Analysis | Corporate FP&A | Profitability Analysis | Finance Business Partner | Annual Budgets | Commercial Sales Forecasting | Patients Claims Analysis, Symphony SHS, IQVIA LAAD, KOMODO Healthless